DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

CUSIP: 25253X207

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Voting Common Shares, no par value
Shares outstanding
52,272,727
Total 13F shares
4,006,054
Share change
+11,186
Total reported value
$10,017,522
Put/Call ratio
42%
Price per share
$2.50
Number of holders
28
Value change
-$427,839
Number of buys
8
Number of sells
19

Security key

25253X207

Report period

Q1 2022

Institutions

28

Top holders

10

Top shareholders of DMAC - DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Stonepine Capital Management, LLC
13F
Company
2.3%
1,194,670
$4,456,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
1.5%
786,552
$2,934,000 31 Dec 2021
13F
Leon G. Cooperman
13F
Individual
0.57%
300,000
$1,119,000 31 Dec 2021
13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC
13F
Company
0.53%
275,000
$1,026,000 31 Dec 2021
13F
Ikarian Capital, LLC
13F
Company
0.4%
209,082
$779,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.32%
167,763
$625,000 31 Dec 2021
13F
Manatuck Hill Partners, LLC
13F
Company
0.28%
144,800
$540,000 31 Dec 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.27%
140,857
$525,000 31 Dec 2021
13F
Anson Funds Management LP
13F
Company
0.25%
130,070
$485,000 31 Dec 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.2%
106,600
$398,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
0.19%
101,283
$378,000 31 Dec 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
65,600
$245,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
0.11%
59,717
$223,000 31 Dec 2021
13F
BlackRock Finance, Inc.
13F
Company
0.11%
58,572
$219,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
0.1%
49,884
$186,000 31 Dec 2021
13F
GROUP ONE TRADING LLC
13F
Company
0.06%
33,868
$126,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
0.05%
23,900
$89,000 31 Dec 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.04%
22,249
$83,000 31 Dec 2021
13F
Jump Financial, LLC
13F
Company
0.04%
21,800
$81,000 31 Dec 2021
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.04%
20,603
$77,000 31 Dec 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.03%
14,065
$52,000 31 Dec 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.02%
11,900
$44,000 31 Dec 2021
13F
MARSHALL WACE, LLP
13F
Company
0.02%
10,031
$38,000 31 Dec 2021
13F
Shay Capital LLC
13F
Company
0.02%
10,000
$37,000 31 Dec 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
9,360
$35,000 31 Dec 2021
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
6,350
$23,000 31 Dec 2021
13F
MassMutual Private Wealth & Trust, FSB
13F
Company
0.01%
4,824
$18,000 31 Dec 2021
13F
UBS Group AG
13F
Company
0.01%
4,618
$17,000 31 Dec 2021
13F
US BANCORP \DE\
13F
Company
0.01%
4,335
$16,000 31 Dec 2021
13F
TD Waterhouse Canada Inc.
13F
Company
0%
1,840
$8,330 31 Dec 2021
13F
NFSG Corp
13F
Company
0%
1,510
$6,000 31 Dec 2021
13F
Patriot Financial Group Insurance Agency, LLC
13F
Company
0%
1,200
$4,000 31 Dec 2021
13F
Sandy Cove Advisors, LLC
13F
Company
0%
1,200
$4,000 31 Dec 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
805
$3,000 31 Dec 2021
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
230
$858 31 Dec 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
162
$1,000 31 Dec 2021
13F
Harry W. Alcorn Jr.
3/4/5
SVP, Clinical Operations
class O/S missing
43,981
$123,147 15 Sep 2021
Sydney A. Gilman
3/4/5
VP, Regulatory Affairs
class O/S missing
25,000
28 Jul 2021

Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2022

As of 31 Mar 2022, DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,006,054 shares. The largest 10 holders included Stonepine Capital Management, LLC, COOPERMAN LEON G, VANGUARD GROUP INC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and BlackRock Inc.. This page lists 28 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
34
Q1 2022 holders
28
Holder diff
-6
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .